0001209191-18-054892.txt : 20181012 0001209191-18-054892.hdr.sgml : 20181012 20181012163620 ACCESSION NUMBER: 0001209191-18-054892 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181010 FILED AS OF DATE: 20181012 DATE AS OF CHANGE: 20181012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harford Simon N.R. CENTRAL INDEX KEY: 0001443705 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 181120600 MAIL ADDRESS: STREET 1: AVON PRODUCTS, INC. STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-10 0 0001322505 ALBIREO PHARMA, INC. ALBO 0001443705 Harford Simon N.R. C/O ALBIREO PHARMA, INC. 10 POST OFFICE SQUARE, SUITE 502 SOUTH BOSTON MA 02109 0 1 0 0 CFO and Treasurer Common Stock 2018-10-10 4 A 0 5000 0.00 A 5000 D Stock Option (right to buy) 27.98 2018-10-10 4 A 0 37500 0.00 A 2028-10-09 Common Stock 37500 37500 D Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on October 10, 2019 with the remainder vesting in equal installments on the last day of 12 consecutive calendar quarters beginning on January 10, 2020 and ending on October 10, 2022. This option vests as to 25% of the shares on October 10, 2019 with the remainder vesting in equal installments on the last day of 12 consecutive calendar quarters beginning on January 10, 2020 and ending on October 10, 2022. /s/ Jason Duncan, Attorney-in-fact 2018-10-12